Publisher
Wiley-VCH Verlag GmbH & Co. KGaA
Reference61 articles.
1. ACGIH (American Conference of Governmental Industrial Hygienists) 2001 Warfarin ACGIH Cincinnati, OH, USA
2. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation;AFI (Atrial Fibrillation Investigators);Arch Intern Med,1994
3. Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis;Andersen;Heart,2008
4. Very low dose warfarin as prophylaxis against ultrasound detected deep vein thrombosis following primary hip replacement;Bern;Am J Hematol,2002
5. Bristol-Myers 2007 Coumadin medication guide Bristol-Myers Squibb Company Princeton, NJ, USA http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/009218s105lblv2.pdf